— Know what they know.
Not Investment Advice

ATRX OTC

Adhera Therapeutics Inc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -99.0% 3Y: -99.5% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $722 mcap · 7M float · 0.0019% daily turnover · Short 94% of daily vol

Balance Sheet Trends

Total Assets
$79K -59.7% ▼
5Y CAGR: -58.2%
Total Liabilities
$22M -12.0% ▼
5Y CAGR: +31.2%
Shareholders Equity
-$22M +11.6% ▲
Cash & Investments
$32K -57.9% ▼
5Y CAGR: -21.4%
Total Debt
$9M +28.8% ▲
5Y CAGR: +35.1%
Net Debt
$9M +29.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$4M$50K$1K$76K$32K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$50K$1K$76K$32K
Net Receivables$48K$0$0$0$0
Inventory$241K$0$0$0$0
Other Current Assets$290K$0$0$0$0
Total Current Assets$5M$420K$1K$196K$79K
Property, Plant & Equip.$72K$0$0$0$0
Goodwill & Intangibles$392K$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$464K$0$0$0$0
Total Assets$5M$420K$1K$196K$79K
— Liabilities —
Accounts Payable$270K$1M$2M$2M$2M
Short-Term Debt$0$5M$6M$7M$9M
Deferred Revenue$0$0$0$9M$0
Other Current Liabilities$126$3M$4M$5M$7M
Total Current Liabilities$2M$10M$15M$25M$22M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$270K$7M$9M$9M$11M
Total Liabilities$2M$10M$15M$25M$22M
— Equity —
Common Stock$65K$65K$67K$102K$19K
Retained Earnings-$26M-$39M-$45M-$53M-$56M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$3M-$10M-$15M-$25M-$22M
Total Liabilities & Equity$5M$420K$1K$196K$79K
— Key Metrics —
Total Debt$0$5M$6M$7M$9M
Net Debt-$4M$5M$6M$7M$9M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms